Introduction and objective
==========================

The rate of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker (ACEi/ARB) at discharge is a quality indicator for acute myocardial infarction (AMI) care. The aim of the study was to evaluate changes in drug prescription before and after the implementation of a managed AMI protocol in patients hospitalized for AMI with moderate to severe left ventricular systolic dysfunction (LVSD).

Patients and methods
====================

A total of 578 consecutive AMI patients (mean age: 68.0 ± 14.4 years) were evaluated. Of these, 92 were eligible for ACEi/ARB therapy at discharge (had LVEF \<40% and/or narrative of LVSD and/or did not have a contraindication to ACEi/ARB and had survived their hospital stay without transfer to another facility). The managed AMI protocol was implemented in a tertiary hospital on 1 March 2005. Quality indicators were prospectively followed by a nurse case-manager, and periodic performance feedback (reports) were given to local hospital managers and clinical staff. Patients were divided into three groups: G1, pre-protocol (March 2004--February 2005); G2, first year post-protocol (March 2005--February 2006); and G3, second year post-protocol (March 2006--February 2007). Statistical analysis was performed using the chi-square test and Fisher\'s exact test. *P*\< 0.05 was considered statistically significant.

Results
=======

The results are presented in Table [1](#T1){ref-type="table"}.

  Group         *n*     \% ACEi/ARB prescription   *P*
  ------------- ------- -------------------------- ------------------
  G1, *n*= 15   8/15    53.3                       0.03 (G1 × G2)
  G2, *n*= 31   26/31   83.8                       0.0004 (G1 × G3)
  G3, *n*= 46   44/46   95.6                       0.05 (G2 × G3)

Conclusion
==========

A significant increase in the rate of ACEi/ARB prescription was observed both in the first and the second years after AMI protocol implementation. A trend toward an increase was also observed when the first and second years post-protocol are compared. These data suggest that managed protocols that include continuous monitoring of quality indicators are useful tools for implementing scientific evidence into clinical practice.
